6,533 followers
New research: COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas: Glioma is the most common malignancy of the central nervous system. Although advances in surgical… https://t.co/Vfkoqu9